Masek, Lawrence - In: Journal of Business Ethics 68 (2006) 2, pp. 143-151
In a recent contribution to this journal, Patrick Tully criticizes my view that the doctrine of double effect does not prohibit a pharmaceutical company from selling a drug that has potentially fatal side-effects and that does not treat a life-threatening condition. Tully alleges my account is...